Background: We evaluated how plasma proteomic signatures in patients with suspected
COVID-19 can unravel the pathophysiology, and determine kinetics and clinical outcome of …

The host response to COVID-19 pathophysiology over the first few days of infection remains
largely unclear, especially the mechanisms in the blood compartment. We report on a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized
by highly heterogeneous manifestations ranging from asymptomatic cases to death for still …

Several elements have an impact on COVID-19, including comorbidities, age and sex. To
determine the protein profile changes in peripheral blood caused by a SARS-CoV-2 …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over forty
million patients worldwide. Although most coronavirus disease 2019 (COVID-19) patients …

Background COVID-19 remains a major public health challenge, requiring the development
of tools to improve diagnosis and inform therapeutic decisions. As dysregulated …

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), whose outbreak in 2019 led to an ongoing pandemic with …

COVID-19 complications still present a huge burden on healthcare systems and warrant
predictive risk models to triage patients and inform early intervention. Here, we profile 893 …

Abstract Purpose Coronavirus disease 2019 (COVID‐19) continues to threaten public health
globally. Severe acute respiratory coronavirus type 2 (SARS‐CoV‐2) infection‐dependent …

OBJECTIVES: COVID-19 is a heterogenous disease. Biomarker-based approaches may
identify patients at risk for severe disease, who may be more likely to benefit from specific …